HS OBTAIN app icon

HS OBTAIN

Definitive Media Corp.

★ 0.00 ratingsMedicalFree

iPhone Screenshots

App screenshotApp screenshotApp screenshot

Description

This is the HS OBTAIN study with Sanofi assessing the efficacy and safety of an anti-TNF-OX40L NANOBODY molecule, SAR442970 in participants with moderate to severe hidradenitis suppurativa.